Global Thrombectomy Devices Market Size, Share, Growth Analysis Report - Forecast 2034

Global Thrombectomy Devices Market: Industry Perspective

The global thrombectomy devices market size was worth around USD 1.52 Billion in 2024 and is predicted to grow to around USD 3.54 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 8.8% between 2025 and 2034. The report analyzes the global thrombectomy devices market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the thrombectomy devices industry.

The report analyzes the thrombectomy devices market’s drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the thrombectomy devices market.

Request Free Sample

Global Thrombectomy Devices Market: Overview

Thrombectomy devices are used to treat blood clots in the veins, arteries, and capillaries. These are meticulously developed devices to reduce blood loss while minimizing injury to the vascular wall during an operation. These devices are available in a variety of diameters and sizes, and the appropriate catheter is chosen based on the afflicted region. Disease and abnormalities such as peripheral arterial disorders, acute myocardial infarction, deep vein thrombosis, neurovascular thrombosis, and pulmonary embolism are all treated with these devices.

Global Thrombectomy Devices Market: Growth Drivers

Stent retrievers are mechanical thrombectomy products from the second generation that are used to treat thrombotic diseases. For the accurate placement of the stent at the occlusion site, a balloon-expanding or self-expanding stent is connected to a Guidewire in-stent retrieval devices. By inflating the stent body, the stent is put at the blockage site and covers the thrombus. The thrombus is then completely removed using a stent extraction device.

Rising reimbursement for thrombectomy operations, growing public-private product development & commercialization expenditures, and enhanced patient priority on less invasive therapeutic techniques are some of the factors propelling the market growth. In addition to this, current product developments by leading companies, as well as key market players' expansion of their presence in emerging countries through the organization of manufacturing facilities, R&D facilities, and distribution networks are likely to propel the thrombectomy devices market forward.

Restraints:

In the field of medical devices, having skilled professionals with appropriate knowledge of the device is essential. The treatment of the patient depends on the diagnosis of the disease and thus accurate diagnosis with proper data & images is required by the providers. With the increase in technological advancements and lack of training in low & middle-income countries may lead to a decrease in the use of thrombectomy devices thereby hampering the market growth. In addition to this, stringent regulatory bodies, lack of awareness among the people regarding the benefits of thrombectomy devices, and poor healthcare infrastructure in rural areas and underdeveloped countries are also some of the factors that may hinder the market growth.

Opportunities:

Technological advancement and implementation of AI in medical devices to drive market growth during the forecast period.

Mechanical thrombectomy devices, which are directed from the wrist or groin through a wire to the blockage, can be used to treat acute ischemic stroke, which is a primary cause of long-term impairment. The clot must be removed as soon as feasible to enhance the patient's prognosis.

In today’s technologically advanced world, without knowing the clot's characteristics, just one out of every three clots can be removed on the first try. Smart Guidewire System incorporating AI-powered tissue sensor allows the guidewire to deliver doctors with acute data on the clot. This is likely to boost the growth of the global market during the forecast market. In addition to this, an increase in the use of automated thrombectomy devices is also expected to fuel market growth during the forecast period.

Challenges:

Multiple passes by the thrombectomy device may cause vascular damage

Numerous passes of a thrombectomy device might cause vascular damage, resulting in vascular re-occlusion, endothelial denudation, and microembolization of distant branches, all of which could have serious consequences for a patient's neurological recovery. In the aged, deep atheroma plaques in the intracerebral circulation may exist, and microscopic damage to such lesions may worsen the pro-thrombotic environment. These factors act as a major challenge for the manufacturers as well as providers over the use of thrombectomy devices.

Key Insights

• As per the analysis shared by our research analyst, the global thrombectomy devices market is estimated to grow annually at a CAGR of around 8.8% over the forecast period (2025-2034).
• Regarding revenue, the global thrombectomy devices market size was valued at around USD 1.52 Billion in 2024 and is projected to reach USD 3.54 Billion by 2034.
• The thrombectomy devices market is projected to grow at a significant rate due to increasing prevalence of hypertension and cardiovascular diseases, the rising demand for continuous and accurate blood pressure monitoring, growing adoption of home healthcare and remote patient monitoring solutions.
• Based on Type, the Mechanical/Fragmentation Thrombectomy Devices segment is expected to lead the global market.
• On the basis of Application, the Cardiovascular Application segment is growing at a high rate and will continue to dominate the global market.
• Based on the End User, the Hospitals and Surgical Centers segment is projected to swipe the largest market share.
• Based on region, North America is predicted to dominate the global market during the forecast period.

Global Thrombectomy Devices Market: Report Scope

Global Thrombectomy Devices Market: Segmentation Analysis

The global thrombectomy devices market is segmented based on Type, Application, End User, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2025 to 2034.

Based on Type, the global thrombectomy devices market is divided into Mechanical/Fragmentation Thrombectomy Devices, Stent Retrievers, Basket/Brush Retrievers, Coil Retrievers, Aspiration Thrombectomy Devices, Rheolytic/Hydrodynamic Thrombectomy Devices, Ultrasonic Thrombectomy Devices.

On the basis of Application, the global thrombectomy devices market is bifurcated into Cardiovascular Application, Peripheral Vascular Application, Neurovascular Application.

By End User, the global thrombectomy devices market is split into Hospitals and Surgical Centers, Ambulatory Surgical Centers, Research Laboratories & Academic Institutes, Other End Users.

The Regional, this segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America,and the Middle East and Africa.

Global Thrombectomy Devices Market: Regional Landscape

The thrombectomy devices market shows strong regional dynamics, with North America leading due to advanced healthcare infrastructure, high adoption of innovative medical technologies, and a significant prevalence of cardiovascular and neurovascular diseases. Europe follows closely, driven by rising healthcare expenditure, increasing awareness about minimally invasive procedures, and supportive government initiatives. Meanwhile, the Asia-Pacific region is experiencing the fastest growth, fueled by improving healthcare systems, growing patient populations, and rising incidences of stroke and peripheral vascular diseases, particularly in countries like China and India. Other regions, including Latin America and the Middle East & Africa, are witnessing steady growth as awareness and access to advanced treatment options gradually expand, supported by emerging healthcare investments and efforts to improve clinical outcomes for vascular diseases.

Recent Developments:

• In February 2024, Cardiovascular Systems, Inc., an innovative medical device company, announced that they have collaborated with Innova Vascular, Inc., a creative medical devices startup that is involved in developing breakthrough medical devices with a minimally invasive approach, in order to develop an effective line of thrombectomy devices. They strive to develop effective aspiration and mechanical devices to functionally treat various diseases such as deep vein thrombosis, peripheral vascular disease, pulmonary embolism, and others.
• In July 2024, Surmodics, Inc., a dominant provider of in vitro diagnostic technologies and medical devices, announced that they have acquired Vetex Medical Limited, an Ireland-based medical device provider. The acquisition expands Surmodics’ offerings to provide utterly effective mechanical thrombectomy devices which is also U.S. Food and Drug Administration (FDA) cleared. Their devices are specially designed to treat various acute diseases including arterial and venous thrombosis.

Global Thrombectomy Devices Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the thrombectomy devices market on a global and regional basis.

The global thrombectomy devices market is dominated by players like:

• Medtronic plc (Ireland)
• Boston Scientific Corporation (U.S.)
• Johnson & Johnson (U.S.)
• Terumo Corporation (Japan)
• Penumbra Inc
• (U.S.)
• Spectranetics Corporation (U.S.)
• Edwards Lifesciences Corporation (U.S.)
• Argon Medical Devices Inc
• (U.S.)
• Teleflex Incorporated (U.S.)

Global Thrombectomy Devices Market: Segmentation Analysis

The global thrombectomy devices market is segmented as follows;

By Type

• Mechanical/Fragmentation Thrombectomy Devices
• Stent Retrievers
• Basket/Brush Retrievers
• Coil Retrievers
• Aspiration Thrombectomy Devices
• Rheolytic/Hydrodynamic Thrombectomy Devices
• Ultrasonic Thrombectom

By Application

• Cardiovascular Application
• Peripheral Vascular Application
• Neurovascular Application

By End User

• Hospitals and Surgical Centers
• Ambulatory Surgical Centers
• Research Laboratories & Academic Institutes
• Other End Users

Global Thrombectomy Devices Market: Regional Segment Analysis

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America